Institut Jules Bordet

Nov 19, 2024 | ejnmmires.springeropen.com | Institut Jules Bordet

Patients enrolled in the LuMEn trial (NCT01842165) were analysed. This single-arm, prospective phase II study included 37 patients with advanced SSTR-positive well-differentiated GEP-NETs of histological grades 1 to 3. Patients were treated with [177Lu]Lu-DOTA-TATE, administered intravenously every 10–12 weeks with a concomitant infusion of a nephroprotective amino acid solution.

Oct 14, 2024 | karger.com | Institut Jules Bordet |Hôpital Erasme

Keywords: 68Ga-DOTATATE positron emission tomography/computed tomography, Mixed neuroendocrine non-neuroendocrine neoplasm, Peptide receptor radionuclide therapy, Somatostatin receptor, Ectopic adrenocorticotropic hormone secretion, Neuroendocrine neoplasm Neuroendocrine neoplasms (NENs) are a heterogeneous group of malignancies arising from different anatomic sites.

Mar 28, 2024 | jamanetwork.com | Aranzazu Fernández-Martínez |Institut Jules Bordet |Katherine A. Hoadley |David Venet

Key PointsQuestion  What is the quantitative association between pathologic complete response (pCR) and event-free survival (EFS) by intrinsic subtype and other gene expression signatures in patients with ERBB2/HER2-positive early breast cancer (EBC) treated in the neoadjuvant setting?

Oct 18, 2023 | karger.com | Institut Jules Bordet

Keywords: Melanoma, Gallbladder, Metastasectomy, Laparoscopy, Port-site metastasis Cutaneous melanoma is known to metastasize to any organ. The most affected sites are the lymph nodes, skin, lungs, brain, and liver. Even if malignant melanoma is one of the most common malignancies associated with metastatic disease of the gastrointestinal (GI) tract [1], GI involvement represents less than 5% of metastatic melanomas.

Jul 11, 2023 | frontiersin.org | Institut Jules Bordet

Hassan Fahmi1* Mehdi Najar1 Sami Alsabri1 Gadid G.